Key result
Lipid-lowering diet plus nutraceuticals improves atherogenic lipid profiles and raises HDL 2b in dyslipidemia.
The combination of a lipid-lowering diet and scientifically proven nutraceutical supplements has the ability to significantly reduce low-density lipoprotein (LDL) cholesterol, increase LDL particle size, decrease LDL particle number, lower trigylcerides and very LDL levels, and increase total and high-density lipoprotein 2b cholesterol. In addition, inflammation, oxidative stress, and immune responses are decreased. In several prospective clinical trials, coronary heart disease and cardiovascular disease have been reduced with many nutraceutical supplements. This nutritional and nutraceutical supplement treatment is a valid alternative for patients who are intolerant to statins, cannot take other drugs for the treatment of dyslipidemia, or prefer alternative treatments. This new approach to lipid management to decrease vascular disease utilizes a functional medicine approach with a broader treatment program that will address the multitude of steps involved in lipid-induced vascular damage.
No takes yet. Share an insight, caveat, or question.
Mark C. Houston (2012) conducted a review in Dyslipidemia. Lipid-lowering diet and nutraceutical supplements was evaluated on Lipid profile parameters (LDL cholesterol, triglycerides, VLDL, HDL 2b) and cardiovascular disease reduction. A lipid-lowering diet combined with nutraceutical supplements reduces LDL cholesterol, triglycerides, and VLDL while increasing HDL 2b cholesterol in patients with dyslipidemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: